按產品、應用、治療適應症、最終用戶和地區分類的血漿市場

Blood Plasma Market, By Product, By Application, By Therapeutic Indication, By End User, By Geography

出版日期: 2025年05月12日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球等離子市場規模預計為 3,880 萬美元，預計到 2032 年將達到 7,950 萬美元，2025 年至 2032 年的年複合成長率（CAGR）為 10.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	3880萬美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	10.80%	2032年價值預測	7950萬美元

全球血漿市場已成為醫療保健產業的重要組成部分，在治療各種慢性和危及生命的疾病中發揮著至關重要的作用。血漿是血液的液體部分，含有用於開發治療產品的必需蛋白質、凝血因子和抗體。該市場的重要性在於它能夠滿足日益成長的血漿衍生療法的需求，這些療法用於治療免疫力缺乏、血友病、神經系統疾病等。隨著這些疾病的盛行率持續上升，加上血漿採集和分離技術的進步，全球血漿市場有望顯著成長。

市場動態：

全球血漿市場受多種因素驅動，例如慢性病盛行率上升、老年人口成長以及免疫球蛋白需求上升。血漿衍生療法在治療原發性免疫力缺乏和神經系統疾病等各種疾病的應用日益廣泛，進一步推動了市場成長。此外，血漿採集和分離技術的進步提高了血漿衍生產品的效率和安全性，從而促進了市場成長。然而，市場也面臨一些限制因素，例如血漿衍生療法的高成本和血液感染疾病的風險。此外，對血漿產品採集、加工和分銷的嚴格監管也可能為市場參與企業帶來挑戰。儘管存在這些市場限制因素，但新興經濟體對血漿衍生療法的需求不斷成長、新型血漿衍生產品的市場開發以及重組血漿蛋白的日益普及，正在為市場提供巨大的成長機會。此外，人們對血漿捐贈益處的認知不斷提高以及全球血漿採集中心的擴張預計將在未來幾年促進市場成長。

本研究的主要特點

本報告對全球等離子市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模（百萬美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、主要亮點、財務業績和策略等參數對全球等離子市場的主要企業進行了概述。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球血漿市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球血漿市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 38.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.80%	2032 Value Projection:	USD 79.5 Mn

The global blood plasma market has emerged as a vital component of the healthcare industry, playing a crucial role in the treatment of various chronic and life-threatening diseases. Blood plasma, the liquid portion of blood, contains essential proteins, clotting factors, and antibodies that are used in the development of therapeutic products. The market's significance lies in its ability to address the growing demand for plasma-derived therapies, which are used to treat conditions such as immune deficiencies, hemophilia, and neurological disorders. As the prevalence of these diseases continues to rise, coupled with advancements in plasma collection and fractionation technologies, the global blood plasma market is poised for substantial growth.

Market Dynamics:

The global blood plasma market is driven by several factors, including the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for immunoglobulins. The expanding applications of plasma-derived therapies in the treatment of various medical conditions, such as primary immunodeficiency disorders and neurological diseases, further fuel the market's growth. Additionally, advancements in plasma collection and fractionation technologies have improved the efficiency and safety of plasma-derived products, thereby boosting market growth. However, the market also faces certain restraints, such as the high cost of plasma-derived therapies and the risk of transmission of blood-borne infections. Moreover, stringent regulations governing the collection, processing, and distribution of blood plasma products can pose challenges to market participants. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for plasma-derived therapies in emerging economies, the development of novel plasma-derived products, and the rising adoption of recombinant plasma proteins. Furthermore, the growing awareness about the benefits of plasma donation and the expansion of plasma collection centers worldwide are expected to contribute to the market's growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global blood plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CSL Behring, Grifols, Takeda Pharmaceutical Company Limited, Octapharma, Kedrion Biopharma, Bio Products Laboratory (BPL), LFB Group, Sanquin Plasma Products, China Biologic Products Holdings, Inc, ADMA Biologics, GC Pharma, CSL Plasma, Emergent BioSolutions, Kamada, and Centurion Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood plasma market

Market Segmentation

Product Insights (Revenue, USD Mn, 2020 - 2032)
- Immunoglobulins
- Albumin
- Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Von Willebrand Factor
- Prothrombin Complex Concentrate
- Fibrinogen Concentrates
- Factor XIII
- Alpha-1 Antitrypsin
- Others
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Hemophilia
- Von Willebrand's Disease
- Others
Therapeutic Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Immunology
- Oncology
- Pulmonology
- Rheumatology
- Transplantation
- Neurology
- Hematology
- Others
Source Insights (Revenue, USD Mn, 2020 - 2032)
- Source Plasma
- Recovered Plasma
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals & Clinics
- Research Laboratories
- Plasma Collection Centers
- Academic & Research Institutes
- Biopharmaceutical Companies
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- CSL Behring
- Grifols
- Takeda Pharmaceutical Company Limited (formerly Shire)
- Octapharma
- Kedrion Biopharma
- Bio Products Laboratory (BPL)
- LFB Group
- Sanquin Plasma Products
- China Biologic Products Holdings, Inc
- ADMA Biologics
- GC Pharma
- CSL Plasma
- Emergent BioSolutions
- Kamada
- Centurion Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Plasma Market, By Product
- Global Blood Plasma Market, By Application
- Global Blood Plasma Market, By Therapeutic Indication
- Global Blood Plasma Market, By Source
- Global Blood Plasma Market, By End User
- Global Blood Plasma Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Plasma Market, By Product, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Coagulation Factor Concentrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrate
Fibrinogen Concentrates
Factor XIII
Alpha-1 Antitrypsin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Blood Plasma Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
- Hypogammaglobulinemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Immunodeficiency Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hemophilia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Von Willebrand's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Blood Plasma Market, By Therapeutic Indication, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pulmonology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Blood Plasma Market, By Source, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Source Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Recovered Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Blood Plasma Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plasma Collection Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Blood Plasma Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited (formerly Shire)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kedrion Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio Products Laboratory (BPL)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LFB Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanquin Plasma Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
China Biologic Products Holdings, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ADMA Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GC Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Plasma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kamada
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Centurion Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies